Deal Wires

INC Research acquires MEK Consulting

Thu, 06 Mar 2014 16:02:56 GMT
INC Research, a therapeutically focused global CRO, has acquired MEK Consulting, a clinical monitoring-focused CRO based in Lebanon with operations in Greece, Turkey and the Middle East and North Africa (MENA) region. The move supports INC’s strategic business expansion in high-growth regions to deliver global trials, and positions the company as a drug development partner in MENA, which offers access to more than 200 million new patients. 
read more

Venn Life Sciences Holdings acquires assets of Evocutis

Thu, 27 Feb 2014 12:32:44 GMT
CRO Venn Life Sciences has announced the acquisition of the intellectual property rights for Labskin, SYN1113 and related equipment of Evocutis, for $287,000 in new ordinary shares in Venn.
read more

UPDATE 1-Cinven to acquire Medpace in $900 million deal -sources

Sun, 23 Feb 2014 22:49:42 GMT
Feb 23 (Reuters) - Private equity firm Cinven Ltd has agreed to acquire pharmaceutical contract research organization Medpace Inc from buyout firm CCMP Capital Advisors LLC for a little over $900...
read more

McKesson Completes Previously Announced Agreements, Secures Celesio Acquisition

Thu, 01 Jan 1970 00:00:00 GMT
SAN FRANCISCO--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK), a leading North American healthcare services and information technology company, confirmed today that it has completed the previously announced agreement with Franz Haniel & Cie. GmbH to acquire their entire holding of Celesio shares. McKesson also confirmed it has completed the previously announced agreement with an affiliate of Elliott Management to acquire Celesio convertible bonds. McKesson now exceeds 75% ownership of Cel
read more

CTI Trial, Clinical Consulting acquire Community Research

Mon, 03 Feb 2014 11:24:50 GMT
CROs CTI Trial and Clinical Consulting recently acquired Community Research, David Blume, managing director of Edgemont Capital, told us.
read more

BioClinica and CCBR-Synarc to merge with Water Street, JLL and Ampersand sharing ownership

Thu, 16 Jan 2014 12:30:35 GMT
BioClinica and CCBR-Synarc have agreed to merge with Water Street, JLL and Ampersand sharing ownership.
read more

McKesson Secures Acquisition of Celesio Through New Agreements

Thu, 01 Jan 1970 00:00:00 GMT
SAN FRANCISCO & FRANKFURT--(BUSINESS WIRE)--McKesson Corporation (NYSE:MCK), a leading North American healthcare services and information technology company, announced today that it has reached an agreement with Franz Haniel & Cie. GmbH (“Haniel”) to acquire their entire holding of Celesio shares for EUR 23.50 per share. In a separate and subsequent agreement, McKesson also announced the acquisition of Celesio convertible bonds from Elliott. These agreements are not subject to any closing c
read more

Quest Diagnostics Inc. Ponies Up $570 Million For

Wed, 22 Jan 2014 00:00:00 GMT
read more

BioClinica, CCBR-SYNARC To Merge

Sat, 18 Jan 2014 08:58:08 GMT
BioClinica and CCBR-SYNARC have signed an agreement to merge their companies
read more

Bridgepoint Development Capital to acquire Quotient Clinical

Thu, 16 Jan 2014 07:14:06 GMT
Quotient Clinical a provider of outsourced early stage drug development services to the pharmaceutical industry has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital for an undisclosed sum.Employing over 200 people Quotie...
read more